新化合物能修复RNA异常 有助开发罕见病新疗法

金融界
15 Apr

日本京都大学等机构研究人员在新一期美国《科学进展》杂志上发表论文说,他们研发出一种低分子化合物,口服后能修复RNA(核糖核酸)错误剪接,从而为治疗法布雷病等基因突变引发的罕见遗传病提供新思路。

研究人员说,这一成果不只是局限于法布雷病,也有可能应用于RNA错误剪接所导致的其他遗传病。这种化合物可以口服并有效地递送到心脏组织,有望在症状出现前预防性治疗相关疾病。

责任编辑:栎树

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10